| 11535661 |
RAGE fusion proteins with improved stability and ligand binding affinity and uses thereof |
Robert Hughes |
2022-12-27 |
|
| 11096998 |
Chimeric antigen receptors comprising BCMA-specific fibronectin type III domains and uses thereof |
Chen-Ni Chin, John Lee, Timothy McCabe, Jill Mooney, Michael Naso |
2021-08-24 |
$283,341,000 |
| 10913784 |
RAGE fusion proteins with improved stability and ligand binding affinity and uses thereof |
Robert Hughes |
2021-02-09 |
|
| 10894836 |
Antibody Fc mutants with ablated effector functions |
McCarthy Stephen, Bernard Scallon, Susan Tam, Omid Vafa |
2021-01-19 |
$146,074,000 |
| 10106617 |
High affinity antibody antagonists of interleukin-13 receptor alpha 1 |
Andrew Donald Nash, Manuel Baca, Louis Jerry Fabri, Dennis Zaller, Zhiqiang An |
2018-10-23 |
|
| 10087243 |
Compositions and methods for phagocyte delivery of anti-staphylococcal agents |
Victor J. Torres, Randall Brezski, Anthony Lynch, Brian Whitaker, Mark Chiu +3 more |
2018-10-02 |
|
| 10053513 |
Antibody Fc mutants with ablated effector functions |
Stephen McCarthy, Bernard Scallon, Susan Tam, Omid Vafa |
2018-08-21 |
$93,496,000 |
| 9777062 |
High affinity antibody antagonists of interleukin-13 receptor alpha 1 |
Andrew Donald Nash, Manuel Baca, Louis Jerry Fabri, Dennis Zaller, Zhiqiang An |
2017-10-03 |
|
| 9644023 |
Compositions and methods for phagocyte delivery of anti-staphylococcal agents |
Victor J. Torres, Randall Brezski, Anthony Lynch, Brian Whitaker, Mark Chiu +3 more |
2017-05-09 |
|
| 9637549 |
Antibody Fc mutants with ablated effector functions |
Omid Vafa |
2017-05-02 |
$67,428,000 |
| 9611328 |
Active protease-resistant antibody FC mutants |
Randall Brezski, Robert Jordan |
2017-04-04 |
$61,751,000 |
| 9371388 |
High affinity antibody antagonists of interleukin-13 receptor alpha 1 |
Andrew Donald Nash, Manuel Baca, Louis Jerry Fabri, Dennis Zaller, Zhiqiang An |
2016-06-21 |
|
| 8961967 |
Antibody Fc mutants with ablated effector functions |
Omid Vafa |
2015-02-24 |
$74,757,000 |
| 8889138 |
Anti-ADDL antibodies and uses thereof |
Paul Acton, Zhiqiang An, Andrew J. Bett, Robert Breese, Elizabeth Chen Dodson +7 more |
2014-11-18 |
$161,322,000 |
| 8871204 |
Active protease-resistant antibody FC mutants |
Randall Brezski, Robert Jordan |
2014-10-28 |
$134,807,000 |
| 8785605 |
Humanized IL-25 antibodies |
Juan Carlos Almagro, Patrick Branigan, Colleen Kane, Susann Taudte, Mark Tornetta +1 more |
2014-07-22 |
$92,648,000 |
| 8613925 |
Anti-IL-13Rα1 antibodies and their uses thereof |
Andrew Donald Nash, Manuel Baca, Louis Jerry Fabri, Dennis Zaller, Zhiqiang An |
2013-12-24 |
|
| 8568722 |
High affinity antibody antagonists of interleukin-13 receptor alpha 1 |
Andrew Donald Nash, Manuel Baca, Louis Jerry Fabri, Dennis Zaller, Zhiqiang An |
2013-10-29 |
|
| 8420093 |
Anti-ADDL monoclonal antibody and use thereof |
Gene Kinney, Zhiqiang An |
2013-04-16 |
$60,818,000 |
| 8383113 |
Anti-ADDL antibodies and uses thereof |
Paul Acton, Zhiqiang An, Andrew J. Bett, Robert Breese, Lei Chang +7 more |
2013-02-26 |
$57,688,000 |
| 8207304 |
Antibody antagonists of interleukin-13 receptor α1 |
Andrew Donald Nash, Louis Jerry Fabri, Dennis Zaller, Zhiqiang An |
2012-06-26 |
|
| 8128930 |
Anti-ADDL antibodies and uses thereof |
Paul Acton, Zhiqiang An, Andrew J. Bett, Robert Breese, Lei Chang +7 more |
2012-03-06 |
$53,485,000 |
| 8105593 |
Anti-ADDL monoclonal antibody and use thereof |
Gene Kinney, Zhiqiang An |
2012-01-31 |
$54,545,000 |
| 7811563 |
Anti-addl antibodies and uses thereof |
Paul Acton, Zhiqiang An, Andrew J. Bett, Robert Breese, Elizabeth Chen Dodson +7 more |
2010-10-12 |
$104,397,000 |
| 7780963 |
Anti-ADDL antibodies and uses thereof |
Paul Acton, Zhiqiang An, Andrew J. Bett, Robert Breese, Lei Chang +7 more |
2010-08-24 |
$88,323,000 |
